Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: A single-center case series
- PMID: 36873313
- PMCID: PMC9975004
- DOI: 10.1016/j.hroo.2022.11.006
Short-term and long-term effects of noninvasive cardiac radioablation for ventricular tachycardia: A single-center case series
Abstract
Background: Noninvasive cardiac radioablation is reported to be effective and safe for the treatment of ventricular tachycardia (VT).
Objective: This study aimed to analyze the acute and long-term effects of VT radioablation.
Methods: Patients with intractable VT or premature ventricular contraction (PVC)-induced cardiomyopathy were included in this study and treated using a single-fraction 25-Gy dose of cardiac radioablation. To quantitatively analyze the acute response after treatment, continuous electrocardiography monitoring was performed from 24 hours before to 48 hours after irradiation and at the 1-month follow-up. Long-term clinical safety and efficacy were assessed 1-year follow-up.
Results: From 2019 to 2020, 6 patients were treated with radioablation for ischemic VT (n = 3), nonischemic VT (n = 2), or PVC-induced cardiomyopathy (n = 1). In the short-term assessment, the total burden of ventricular beats decreased by 49% within 24 hours after radioablation and further decreased by 70% at 1 month. The VT component decreased earlier and more dramatically than the PVC component (decreased by 91% and 57% at 1 month, respectively). In the long-term assessment, 5 patients showed complete (n = 3) or partial (n = 2) remission of ventricular arrhythmias. One patient showed recurrence at 10 months, which was successfully suppressed with medical treatment. The posttreatment PVC coupling interval was prolonged (+38 ms at 1 month). Ischemic VT burden decreased more markedly than nonischemic VT burden after radioablation.
Conclusion: In this small case series of 6 patients, without a comparison group, cardiac radioablation appeared to decrease the intractable VT burden. A therapeutic effect was apparent within 1-2 days after treatment but was variable by etiology of cardiomyopathy.
Keywords: Cardiac radioablation; Early antiarrhythmic effect; Electrophysiologic change; Safety; Ventricular tachycardia.
© 2022 Heart Rhythm Society. Published by Elsevier Inc.
Figures




Similar articles
-
Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.Circulation. 2019 Jan 15;139(3):313-321. doi: 10.1161/CIRCULATIONAHA.118.038261. Circulation. 2019. PMID: 30586734 Free PMC article. Clinical Trial.
-
Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study.J Interv Card Electrophysiol. 2021 Nov;62(2):427-439. doi: 10.1007/s10840-021-01060-5. Epub 2021 Oct 5. J Interv Card Electrophysiol. 2021. PMID: 34609691 Free PMC article. Clinical Trial.
-
Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia.Heart Rhythm. 2020 Aug;17(8):1241-1248. doi: 10.1016/j.hrthm.2020.02.036. Epub 2020 Mar 6. Heart Rhythm. 2020. PMID: 32151737
-
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease - A systematic review.Radiother Oncol. 2021 Sep;162:132-139. doi: 10.1016/j.radonc.2021.06.036. Epub 2021 Jul 4. Radiother Oncol. 2021. PMID: 34233215
-
Cardiac radioablation in the treatment of ventricular tachycardia.Clin Transl Radiat Oncol. 2021 Feb 12;31:71-79. doi: 10.1016/j.ctro.2021.02.005. eCollection 2021 Nov. Clin Transl Radiat Oncol. 2021. PMID: 34646951 Free PMC article. Review.
Cited by
-
Stereotactic arrhythmia radioablation for ventricular tachycardia: a review of clinical trials and emerging roles of imaging.J Radiat Res. 2025 Jan 22;66(1):1-9. doi: 10.1093/jrr/rrae090. J Radiat Res. 2025. PMID: 39656944 Free PMC article. Review.
-
Stereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review.Europace. 2024 Dec 26;27(1):euae305. doi: 10.1093/europace/euae305. Europace. 2024. PMID: 39716963 Free PMC article.
-
Technical aspects of SBRT for therapy-refractory ventricular tachycardia: a systematic review for radiation oncologists.Radiat Oncol. 2025 Aug 29;20(1):136. doi: 10.1186/s13014-025-02704-w. Radiat Oncol. 2025. PMID: 40883833 Free PMC article. Review.
-
Patient selection, ventricular tachycardia substrate delineation, and data transfer for stereotactic arrhythmia radioablation: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology and the Heart Rhythm Society.Europace. 2025 Mar 28;27(4):euae214. doi: 10.1093/europace/euae214. Europace. 2025. PMID: 39177652 Free PMC article.
-
Stereotactic arrhythmia radioablation and its implications for modern cardiac electrophysiology: results of an EHRA survey.Europace. 2024 May 2;26(5):euae110. doi: 10.1093/europace/euae110. Europace. 2024. PMID: 38666444 Free PMC article.
References
-
- Bode F., Blanck O., Gebhard M., et al. Pulmonary vein isolation by radiosurgery: implications for noninvasive treatment of atrial fibrillation. Europace. 2015;17:1868–1874. - PubMed
-
- Neuwirth R., Cvek J., Knybel L., et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace. 2019;21:1088–1095. - PubMed
LinkOut - more resources
Full Text Sources